Checks for measles IgG antibodies, used as presumptive evidence of immunity when there is no sign of acute infection.
1 biomarker as listed by Blue Horizon Medicals.
This test looks for IgG antibodies to measles in your blood. Their presence is commonly treated as presumptive evidence of immunity, provided there are no clinical signs suggesting an acute infection at the time of testing; a negative or equivocal result may mean immunity cannot be confirmed.
As a single-marker test it sits a little below the middle for clinical depth, in the 36th percentile of the immunity and infection tests we track, since many other tests in that category cover several markers. On price it stands out: at £41.25 it costs around 71% less than the £144.25 median across the 79 similarly sized immunity tests we track. Blue Horizon does not list a directly comparable competitor test for us to name here.
The listing publishes a short description, the marker, sample type, collection options and turnaround, supporting a solid clarity score. Collection needs a venous draw at a clinic or a nurse home visit rather than an at-home kit, and results take around 3 days. Results are reviewed by a doctor, and Blue Horizon uses UKAS ISO 15189 partner labs, with a Trustpilot score of 4.2 from 395 reviews.
This suits someone who needs to provide evidence of measles immunity status, for example ahead of travel, a new job in healthcare or education, or pregnancy planning, where a GP or employer has asked for antibody evidence rather than vaccination records. It is not a general infection screen, so if you have symptoms of an acute illness you should see a GP rather than relying on this test alone.
You provide a venous blood sample at a clinic or via a nurse home visit; there is no at-home finger-prick option for this test. Results are typically available within around 3 days and are reviewed by a doctor before you receive them.
A single-marker blood test for measles IgG antibodies, used as presumptive evidence of immunity when there are no signs of acute infection. At £41.25 it costs around 71% less than the £144.25 median across the immunity tests we track, though it needs a venous draw rather than an at-home kit.
The listing publishes a short description, the full biomarker list, a stated turnaround, clear collection options, the sample type; it does not state what the report looks like.
1 biomarkers, placing it in the 36th percentile of immunity tests we track.
A blood sample taken at home by a visiting nurse or phlebotomist; with a venous or clinic option as well; a home nurse visit is offered; results in around 3 days, in line with or faster than similar tests.
Results are reviewed by a doctor; the provider does not describe the report format.
Trustpilot 4.2 from 395 reviews; accredited lab (UKAS ISO 15189 partner labs); trading 17+ years.
£41.25 against a median of £144.25 for the 79 similarly sized immunity tests we track (-71%).
Calculated 13 September 2026 from the facts we hold about this test and provider, using our published scoring formula. Scores are not hand-edited.
Highly rated for depth and priced well below the market
An 8-marker blood test covering white and red blood cells, vitamin D, B12, iron status and inflammation, for a broad check of immune-related health.
Six-marker immunity panel below the category median
A six-marker blood panel covering IgG, IgM and IgA antibodies plus total protein, albumin and globulin, for anyone investigating frequent infections or possible immune deficiency.
Combined Covid tests, discontinued from 30 Sept 2026
A combined blood test measuring both nucleocapsid antibodies, which indicate past infection, and spike protein antibodies, which indicate a vaccine or infection response.
Broad 13-marker urine panel, competitively priced
A urine analysis under the microscope plus a culture to check for bacteria, covering signs of infection, kidney health and metabolic changes. Suits monitoring urinary symptoms or investigating an abnormal result.
